 CHARLOTTESVILLE, Va. and CARMEL, Ind., Nov. 07, 2022 GLOBE NEWSWIRE -- Acumen Pharmaceuticals, Inc. NASDAQ: ABOS, a clinical-stage biopharmaceutical company focused on the development of novel targeted therapeutics for Alzheimers disease, today announced that the Company will report its financial results for the third quarter 2022 on Monday, November 14, 2022. The Company will host a conference call and live audio webcast at 4:30 p.m. ET to provide a business and financial update. 